FOR IMMEDIATE RELEASE
Press Contact: Rachel Glassford (888) 744-6295
Date: April 5, 2016
Kitchener, Ontario – SigmaXL Inc. is pleased to announce that DiscoverSim Version 2, our Monte Carlo simulation and global optimization Excel add-in, has been formally validated by a major FDA regulated medical devices company.
“Our medical device company has found Monte Carlo simulation incredibly valuable in developing medical products that are robust over the full range of use conditions. The convenience and technical support for DiscoverSim, and the powerful built-in optimizer, are drivers for widespread use of this tool,” said the company Engineering Program Director.
DiscoverSim is bundled with MIDACO, one of the world’s strongest evolutionary solvers for global optimization. MIDACO was developed in collaboration with the European Space Agency (ESA) to solve some of the most difficult space trajectory problems. It holds the benchmark world record best solution to Full Messenger (Mission to Mercury) in the ESA Global Trajectory Optimization Database.
“DiscoverSim enables you to quantify your risk through Monte Carlo simulation and minimize your risk with global optimization,” said John Noguera, CTO, SigmaXL. “Now with MIDACO, you can be confident that a best solution will be found for even the most difficult of business optimization problems.”
DiscoverSim is ideal for “Design For Six Sigma” (DFSS), Risk and Project Management and comes bundled with SigmaXL Version 7 for Lean Six Sigma statistical and graphical analysis.
A free 30-day trial version is available for download from the SigmaXL website at: www.SigmaXL.com.
About SigmaXL Inc.
SigmaXL is a leading provider of user friendly Excel Add-ins for Lean Six Sigma tools and Monte Carlo Simulation. SigmaXL customers include market leaders like Agilent, Diebold, FedEx, Microsoft, Motorola, and Shell. SigmaXL software is also used by numerous colleges, universities and government agencies.
For more information, visit http://www.SigmaXL.com or call 1-888-SigmaXL (888-744-6295).
